Jove
Visualize
Contact Us

Related Concept Videos

Infertility in Females01:28

Infertility in Females

291
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
291
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

347
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
347
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

464
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
464
Ovaries01:26

Ovaries

798
The ovaries are roughly the size of almonds and measure approximately 2 to 3 centimeters in length. These paired structures are situated within the pelvic region and are anchored by the mesovarium—a peritoneal extension that also connects them to the wider structure of the broad ligament. The support system extends to the suspensory ligament, housing blood and lymphatic vessels. In addition, the ovarian ligament tethers the ovaries to the uterus.
On the ovarian surface, a layer of...
798
Ovarian Cycle01:27

Ovarian Cycle

1.1K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.1K
Oogenesis02:07

Oogenesis

63.6K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fattening mother's milk with oxytocin.

Science signaling·2026
Same author

In Science Journals.

Science (New York, N.Y.)·2026
Same author

In Science Journals.

Science (New York, N.Y.)·2026
Same author

In Science Journals.

Science (New York, N.Y.)·2026
Same author

RXRα marks the spot for Crohn's disease.

Science signaling·2026
Same author

In Science Journals.

Science (New York, N.Y.)·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 23, 2025

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
04:49

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome

Published on: July 5, 2024

992

A gut punch for PCOS.

Wei Wong1

  • 1Science Signaling, AAAS, Washington, DC 20005, USA.

Science Signaling
|June 18, 2024
PubMed
Summary
This summary is machine-generated.

A gut bacteria metabolite suppresses glucagon-like peptide-1 (GLP-1) release, a key hormone in metabolic regulation. This suppression is identified as a novel cause of polycystic ovary syndrome (PCOS) in women.

More Related Videos

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

2.9K
A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
08:20

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

11.2K

Related Experiment Videos

Last Updated: Jun 23, 2025

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
04:49

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome

Published on: July 5, 2024

992
Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

2.9K
A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
08:20

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

11.2K

Area of Science:

  • Endocrinology
  • Microbiome Research
  • Reproductive Medicine

Background:

  • Polycystic ovary syndrome (PCOS) is a complex endocrine disorder affecting reproductive and metabolic health.
  • The role of the gut microbiome in PCOS pathogenesis is increasingly recognized but not fully elucidated.
  • Glucagon-like peptide-1 (GLP-1) is a crucial incretin hormone involved in glucose homeostasis and appetite regulation, with potential implications in PCOS.

Purpose of the Study:

  • To investigate the causal link between gut microbiota metabolites and the development of PCOS.
  • To identify specific microbial metabolites that influence GLP-1 secretion.
  • To elucidate the mechanism by which altered GLP-1 signaling contributes to PCOS pathophysiology.

Main Methods:

  • Analysis of fecal microbiota composition and metabolite profiling in PCOS patients and controls.
  • In vitro studies using intestinal cell lines to assess the impact of identified metabolites on GLP-1 release.
  • In vivo studies using animal models to confirm the role of specific metabolites and GLP-1 suppression in PCOS induction.

Main Results:

  • A specific gut microbiota-derived metabolite was found to significantly suppress GLP-1 release.
  • Reduced GLP-1 levels correlated with key PCOS phenotypes, including hyperandrogenism and anovulation, in experimental models.
  • Depletion of the identified metabolite or restoration of GLP-1 signaling ameliorated PCOS symptoms.

Conclusions:

  • Gut microbiota metabolites can directly suppress GLP-1 secretion, representing a novel mechanism in PCOS development.
  • Targeting gut microbiota or modulating GLP-1 signaling may offer new therapeutic strategies for PCOS.
  • This study highlights the intricate interplay between the gut microbiome and endocrine function in reproductive health disorders.